📑NSP-2021-08 Suministro de farmacos con exclusividad para el Instituto Catalan de Oncologia
Procurement process summary
This process is to purchase NSP-2021-08 Suministro de farmacos con exclusividad para el Instituto Catalan de Oncologia.
This contract was awarded by 🇪🇸 Instituto Catalán de Oncologia for an amount of EUR 828,695 to 1 supplier. It was published on 2021-11-17 through direct
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Instituto Catalán de Oncologia Publication date2021-11-17 DescriptionNSP-2021-08 Suministro de farmacos con exclusividad para el Instituto Catalan de OncologiaAwards
This award was granted to PFIZER, S.L. by Instituto Catalán de Oncologia for an amount of EUR 828,695. The procurement process was conducted through direct for the category of goods. The award was granted on 2021-11-11. This is award number 2.
This contract has multiple awards. This is award number 2. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇪🇸 PFIZER, S.L. | EUR 828,695 | 2021-11-11 | 2 |
Market context and opportunities
The execution of this contract allows the entity Instituto Catalán de Oncologia to fulfill its public service objectives efficiently.
The direct purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-49f85d45-1a59-47c1-8fca-e7b75ed0cf91-award-2Publication date2021-11-17Award date2021-11-11CategoriesgoodsPurchase modalitydirectMethod detailspt_award_contract_without_callData sources
This website publishes data from official sources, public databases published by governments. Public access to data is a civil right. The data helps citizen monitor of government spending. The data here is public by law. It does not contain personal data. There is no privacy violation. Privacy policy.
